| The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an … F Musarrat, V Chouljenko, A Dahal, R Nabi, T Chouljenko, SD Jois, ... Journal of medical virology 92 (10), 2087-2095, 2020 | 181 | 2020 |
| Design of β-turn based therapeutic agents K Suat, SDS Jois Current pharmaceutical design 9 (15), 1209-1224, 2003 | 168 | 2003 |
| Peptides, peptidomimetics, and polypeptides from marine sources: a wealth of natural sources for pharmaceutical applications R Sable, P Parajuli, S Jois Marine drugs 15 (4), 124, 2017 | 118 | 2017 |
| Separation and analysis of peptides and proteins C Schoneich, AFR Huhmer, SR Rabel, JF Stobaugh, SDS Jois, CK Larive, ... Analytical chemistry 67 (12), 155-181, 1995 | 115 | 1995 |
| Phthalocyanine–peptide conjugates for epidermal growth factor receptor targeting BG Ongarora, KR Fontenot, X Hu, I Sehgal, SD Satyanarayana-Jois, ... Journal of medicinal chemistry 55 (8), 3725-3738, 2012 | 112 | 2012 |
| Surfing the protein-protein interaction surface using docking methods: application to the design of PPI inhibitors R Sable, S Jois Molecules 20 (6), 11569-11603, 2015 | 89 | 2015 |
| Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment JJ Sonju, A Dahal, SS Singh, SD Jois Journal of Controlled Release 329, 624-644, 2021 | 88 | 2021 |
| Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis KN Sulochana, H Fan, S Jois, V Subramanian, F Sun, RM Kini, R Ge Journal of Biological Chemistry 280 (30), 27935-27948, 2005 | 87 | 2005 |
| An N6-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells MB Uddin, KR Roy, SB Hosain, SK Khiste, RA Hill, SD Jois, Y Zhao, ... Biochemical pharmacology 160, 134-145, 2019 | 83 | 2019 |
| Increasing paracellular porosity by E-cadherin peptides: discovery of bulge and groove regions in the EC1-domain of E-cadherin E Sinaga, SDS Jois, M Avery, IT Makagiansar, USF Tambunan, KL Audus, ... Pharmaceutical research 19, 1170-1179, 2002 | 76 | 2002 |
| Cancer vaccines, treatment of the future: with emphasis on HER2-positive breast cancer S Pallerla, ARM Abdul, J Comeau, S Jois International journal of molecular sciences 22 (2), 779, 2021 | 71 | 2021 |
| The effect of conformation on the membrane permeation of coumarinic acid‐and phenylpropionic acid‐based cyclic prodrugs of opioid peptides OS Gudmundsson, SDS Jois, DGV Velde, TJ Siahaan, RT Borchardt, ... The Journal of peptide research 53 (4), 383-392, 1999 | 69 | 1999 |
| Molecular targeting of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) NEM Kaufman, S Dhingra, SD Jois, MGH Vicente Molecules 26 (4), 1076, 2021 | 61 | 2021 |
| Synthesis of BODIPY-peptide conjugates for fluorescence labeling of EGFR overexpressing cells N Zhao, TM Williams, Z Zhou, FR Fronczek, M Sibrian-Vazquez, SD Jois, ... Bioconjugate chemistry 28 (5), 1566-1579, 2017 | 60 | 2017 |
| Structure, self-assembly, and dual role of a β-defensin-like peptide from the Chinese soft-shelled turtle eggshell matrix R Lakshminarayanan, S Vivekanandan, RP Samy, Y Banerjee, ... Journal of the American Chemical Society 130 (14), 4660-4668, 2008 | 60 | 2008 |
| The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide S Gangwar, SDS Jois, TJ Siahaan, DG Vander Velde, VJ Stella, ... Pharmaceutical research 13, 1657-1662, 1996 | 59 | 1996 |
| GHRH antagonists support lung endothelial barrier function MA Uddin, MS Akhter, SS Singh, KT Kubra, AV Schally, S Jois, ... Tissue Barriers 7 (4), 1669989, 2019 | 54 | 2019 |
| Protein Folding Determinants: Structural Features Determining Alternative Disulfide Pairing in α- and χ/λ-Conotoxins, TS Kang, Z Radić, TT Talley, SDS Jois, P Taylor, RM Kini Biochemistry 46 (11), 3338-3355, 2007 | 54 | 2007 |
| Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor KS Abdelwahed, AB Siddique, MM Mohyeldin, MH Qusa, AA Goda, ... Pharmacological research 158, 104847, 2020 | 53 | 2020 |
| A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor DCW Tan, RM Kini, SDS Jois, DKF Lim, L Xin, R Ge FEBS letters 494 (3), 150-156, 2001 | 52 | 2001 |
